Alnylam Pharmaceuticals
ALNY
#559
Rank
$42.75 B
Marketcap
$322.38
Share price
-0.37%
Change (1 day)
38.32%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company